1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gen für gen-analyse in der MAGNITUDE-studie mit niraparib (NIRA) und abirateronacetat plus prednison (AAP) bei patienten (pts) mit metastasiertem kastrationsresistentem prostatakarzinom (mCRPC) und homologen rekombinationsreparatur (HRR) genveränderungen
    Meeting Abstract

    Schlack, K.; Sandhu, S.; Attard, G.; Olmos, D.; Efstathiou, E.; Castro, E.; Rathkopf, D. E.; Smith, M. R.; Roubaud, G.; Small, E. J.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Entitäten-unabhängige sicherheit und wirksamkeit von erdafitinib bei patienten mit fortgeschrittenen soliden tumoren mit präspezifizierten genomischen fgfraberrationen (RAGNAR Interimanalyse)
    Meeting Abstract

    Schuler, M.; Loriot, Y.; Iyer, G.; Witt, O.; Doi, T.; Qin, S.; Tabernero, J.; Reardon, D. A.; Massard, C.; Palmer, D. H.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Raising the level of cancer care: Feasibility and reported benefit of a virtual tumor board
    Meeting Abstract

    Chiec, L.; Dempsey, N.; Agarwal, M. S.; Ogden, J. R.; Broughman, J. R.; Mayo, Z.; Shonkwiler, E.; Chaby, M.; Socinski, M. A.; Pegram, M. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Craniocaudal nodal length (CCNL) as a risk-factor for relapse in stage I non-seminomatous germ cell tumors (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Fernandes, M. C.; Funt, S. A.; Bromberg, M.; Knezevic, A.; Nikolovski, I.; Feldman, D. R.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I study of intravesical anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG) therapy
    Meeting Abstract

    Wong, J. L.; Knorr, D.; Whiting, K.; Seshan, V. E.; Pietzak, E. J.; Donahue, T. F.; Cha, E. K.; Goh, A. C.; Smith, R.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Results for patients with muscle-invasive bladder cancer (MIBC) in the CheckMate 274 trial
    Meeting Abstract

    Witjes, A. A.; Bajorin, D. F.; Galsky, M. D.; Gschwend, J. E.; Tomita, Y.; Lebret, T.; Pérez-Valderrama, B.; Bamias, A.; Collette, S.; Zhang, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Impact of subsequent therapies in patients (pts) with advanced renal cell carcinoma (aRCC) receiving lenvatinib plus pembrolizumab (LEN + PEMBRO) or sunitinib (SUN) in the CLEAR study
    Meeting Abstract

    Voss, M. H.; Powles, T.; McGregor, B. A.; Porta, C.; Grünwald, V.; Merchan, J. R.; Rolland, F.; Maroto-Rey, P.; Goh, J. C.; Xing, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • [(177)Lu]Lu-PSMA-617 in PSMA-positive metastatic castration-resistant prostate cancer: Prior and concomitant treatment subgroup analyses of the VISION trial
    Meeting Abstract

    Vaishampayan, N.; Morris, M. J.; Krause, B. J.; Vogelzang, N. J.; Kendi, A. T.; Nordquist, L. T.; Calais, J.; Nagarajah, J.; Beer, T. M.; El-Haddad, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management
    Meeting Abstract

    Truong, H.; Ravichandran, V.; Kemel, Y.; Knezevic, A.; Gleeson, J. P.; Benfante, N.; Bromberg, M.; Bolos, M.; Joseph, G.; Matulewicz, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Association between depth of response (DepOR) and clinical outcomes: Exploratory analysis in patients with previously untreated advanced renal cell carcinoma (aRCC) in CheckMate 9ER
    Meeting Abstract

    Suárez, C.; Choueiri, T. K.; Burotto, M.; Powles, T.; Bourlon, M. T.; Shah, A. Y.; Tomita, Y.; Bedke, J.; Zhang, J.; Simsek, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save